Gene · 3732
Papers4,224
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
741 to 760 of 4,224
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Drug-Related Problems of Children With Chronic Diseases in a Chinese Primary Health Care Institution: A Cross-Sectional Study. | Front Pharmacol | 2022 | 35924066 | PubTator, text mining | PubMed |
| Looking for the Genes Related to Lung Cancer From Nasal Epithelial Cells by Network and Pathway Analysis. | Front Genet | 2022 | 35923697 | PubTator, text mining | PubMed |
| MALAT1-miRNAs network regulate thymidylate synthase and affect 5FU-based chemotherapy. | Mol Med | 2022 | 35922756 | PubTator, text mining | PubMed |
| TRIM66 Promotes Malignant Progression of Non-Small-Cell Lung Cancer Cells via Targeting MMP9. | Comput Math Methods Med | 2022 | 35912155 | PubTator, text mining | PubMed |
| Multi-Data Integration Towards a Global Understanding of the Neurological Impact of Human Brain Severe Acute Respiratory Syndrome Coronavirus 2 Infection. | Front Integr Neurosci | 2022 | 35910337 | PubTator, text mining | PubMed |
| Mesenchymal Stem Cell-Derived Exosomal MiRNAs Promote M2 Macrophages Polarization: Therapeutic Opportunities for Spinal Cord Injury. | Front Mol Neurosci | 2022 | 35903172 | PubTator, text mining | PubMed |
| The potential use of mesenchymal stem cells and their exosomes in Parkinson's disease treatment. | Stem Cell Res Ther | 2022 | 35902981 | PubTator, text mining | PubMed |
| PD-1 directed immunotherapy alters Tfh and humoral immune responses to seasonal influenza vaccine. | Nat Immunol | 2022 | 35902637 | PubTator, text mining | PubMed |
| Study on Axial Tensile Strain Rate Effect on Concrete Based on Experimental Investigation and Numerical Simulation. | Materials (Basel) | 2022 | 35897596 | PubTator, text mining | PubMed |
| Crystal Growth, Thermal and Spectral Properties of Er: LGGG Crystal. | Materials (Basel) | 2022 | 35888286 | PubTator, text mining | PubMed |
| Cytochrome P450 27C1 Level Dictates Lung Cancer Tumorigenicity and Sensitivity towards Multiple Anticancer Agents and Its Potential Interplay with the IGF-1R/Akt/p53 Signaling Pathway. | Int J Mol Sci | 2022 | 35887201 | PubTator, text mining | PubMed |
| P63 and P73 Activation in Cancers with p53 Mutation. | Biomedicines | 2022 | 35884795 | PubTator, text mining | PubMed |
| Invasive Candidiasis: Update and Current Challenges in the Management of This Mycosis in South America. | Antibiotics (Basel) | 2022 | 35884131 | PubTator, text mining | PubMed |
| Transcriptomic and proteomic retinal pigment epithelium signatures of age-related macular degeneration. | Nat Commun | 2022 | 35882847 | PubTator, text mining | PubMed |
| Advances in the Regulation of Macrophage Polarization by Mesenchymal Stem Cells and Implications for ALI/ARDS Treatment. | Front Immunol | 2022 | 35880175 | PubTator, text mining | PubMed |
| Recent advances in optical label-free characterization of extracellular vesicles. | Nanophotonics | 2022 | 35880114 | PubTator, text mining | PubMed |
| Horizon of exosome-mediated bone tissue regeneration: The all-rounder role in biomaterial engineering. | Mater Today Bio | 2022 | 35875196 | PubTator, text mining | PubMed |
| Role of extracellular vesicles in lung diseases. | Chin Med J (Engl) | 2022 | 35866573 | PubTator, text mining | PubMed |
| Cancer-associated fibroblast-derived exosomal microRNA-20a suppresses the PTEN/PI3K-AKT pathway to promote the progression and chemoresistance of non-small cell lung cancer. | Clin Transl Med | 2022 | 35857905 | PubTator, text mining | PubMed |
| A peptide interfering with the dimerization of oncogenic KITENIN protein and its stability suppresses colorectal tumour progression. | Clin Transl Med | 2022 | 35853101 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3732/papers?page=38